-
Gains return to Europe on suggested tariff flexibility
-
German manufacturing output increases for the first time in almost 2 years
-
SAP surpasses Novo Nordisk as Europe’s most valuable public company
As the upcoming April 2 deadline for reciprocal tariffs is becoming less and less feared due to Trump’s flexibility remarks, the growing risk appetite sends European markets up on Monday. At the moment, German DAX adds 0,35%, French CAC40 is up 0,15%, while British FTSE 100 gains 0,1%.
Some insights from this month's PMIs for Eurozone economies also contribute to sustained optimism in today’s trading. The German Manufacturing Output Index has risen above the expectations to its 34-month high (50.7), entering an expansion territory for the first time in almost two years.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile app
Volatility on European markets today. Source: xStation5
DE40 (H1)
Following recent corrections, the contracts for German DAX opened bullishly on generally improving market sentiment, inspired by the recent suggestions made by Donald Trump. DE40 experienced high volatility at the publication of March PMIs in the Eurozone and is currently trading where it opened on Friday, prior to declines. The index bounced back from the 24-period EMA (light purple), suggesting a potential test of the recent ATH (~23 500) coming in the future. On the other hand, breaking below EMA120 (dark purple) might herald a comeback to the frequently tested support around 22 300.
Source: xStation5
Company news:
-
Bayer AG's (BAYN.DE) shares fell 7% after a Georgia jury ordered the company to pay nearly $2.1 billion over claims its Roundup weedkiller caused cancer. This marks another setback in ongoing litigation, which has already cost Bayer around $10 billion. The company plans to appeal the decision.
-
RWE AG (RWE.DE) has been urged by Elliott Investment Management to increase share buybacks after acquiring a nearly 5% stake in the company. The activist investor criticized RWE for lacking clarity on shareholder returns and called for more significant buybacks. RWE has been reducing green investments amid risks in the US. RWE’s shares are up 2.2%.
-
SAP (SAP.DE) has surpassed Novo Nordisk to become Europe’s most valuable public company, with shares rising 40% over the past year. The German software giant’s growth is driven by its shift to cloud services and AI, while Novo Nordisk struggles with disappointing drug trials. SAP’s market value reached €312 billion.
-
Stellantis (STLAM.IT) is offering voluntary buyouts to some workers at its US factories in Michigan, Ohio, and Illinois. The buyouts include termination and retirement incentive packages, part of a review to improve efficiency and maintain competitiveness. Employees have until May 8 to respond to the offer. The shares are up 0.8%.
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
